{
    "cancelStatus": "0",
    "cancelDate": null,
    "cancelReason": [],
    "licid": "51058242",
    "validDate": "2029-04-02 00:00:00.000",
    "issueDate": "2014-04-02 00:00:00.000",
    "licKind": "10",
    "oldLicid": null,
    "certNo": "DHY05105824201",
    "prodNameC": "\"台耀\"伊馬替尼",
    "prodNameE": "Imatinib Mesylate \"F.L.\"",
    "indicationsName": [
        "治療正值急性轉化期(BLAST CRISIS)、加速期或經ALPHA-干擾素治療無效之慢性期的慢性骨髓性白血病(CML)患者，治療成年人無法手術切除或轉移的惡性胃腸道基質瘤。用於治療初診斷為慢性骨髓性白血病(CML)的病人。治療切診斷為費城染色體陽性急性淋巴性白血病(Ph+ALL)且併用化療之成年及兒童患者。做為治療成人復發性或難治性費城染色體陽性急性淋巴性白血病(Ph+ALL)之單一療法。治療患有與血小板衍生生長因子受體(PDGFR)基因重組相關之骨髓發育不全症候群(MDS)\/骨髓增生性疾病(MPD)之成人患者。治療患有系統性肥大增生症(SM)，限具FIP1L1-PDGFR基因變異且不具有c-Kit基因D816V突變之成人患者。治療嗜伊紅性白血球增加症候群(HES)與或慢性嗜伊紅性白血病(CEL)且有血小板衍生生長因子受體(PDGFR)基因重組之成人患者。作為成人KIT(CD 117)陽性胃腸道基質瘤完全切除(complete gross resection)後之術後輔助治療。治療患有無法手術切除、復發性或轉移性且有血小板衍生生長因子體(PDGFR)基因重組之隆突性皮膚纖維肉瘤(DFSP)之成人患者。"
    ],
    "does": "0041",
    "packageUnit": [
        {
            "packageSpec": "0.5公斤以上",
            "packageUnit": "D1"
        }
    ],
    "medMCode": "01",
    "maMedCode": "",
    "medDCode": "E",
    "ingredientsDesc": [
        "Imatinib Mesylate 98.0~102.0% (on anhydrous basis)"
    ],
    "restraintItemsCode": [
        "01"
    ],
    "applicantName": "台耀化學股份有限公司",
    "applicantAddr": "桃園市蘆竹區和平街36號",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "台耀化學股份有限公司蘆竹廠",
            "factoryAddr": "桃園市蘆竹區和平街36、36-1號、油管路2段398號",
            "factoryCompanyAddr": "",
            "countryCode": "TW",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "6132051075",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "Imatinib Mesylate 98.0~102.0% (on anhydrous basis)",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [
        {
            "licChgDocId": "BDC4CEC0-728D-4D47-B8BE-175442C40A89",
            "approvedDocNo": "1110809558",
            "approvedDate": "2022-07-14",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        }
    ],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01XE01"
        }
    ]
}